You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 5, 2024

CLINICAL TRIALS PROFILE FOR CEFACLOR


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for CEFACLOR

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00084201 ↗ Interactions Between Cranberry Juice and Antibiotics Used to Treat Urinary Tract Infections Completed National Center for Complementary and Integrative Health (NCCIH) N/A 2006-07-01 The purpose of study is to determine whether cranberry juice interacts with antibiotics used to treat urinary tract infections (UTIs).
NCT00257140 ↗ A Study of the Safety and Effectiveness of Levofloxacin Compared With Cefaclor in the Treatment of Adults With Chronic Bronchitis Experiencing Rapid Onset of Worsening of Symptoms Caused by Bacteria Completed PriCara, Unit of Ortho-McNeil, Inc. Phase 2/Phase 3 1931-06-01 The purpose of this study is to evaluate the safety and effectiveness of levofloxacin, an antibiotic, compared with cefaclor, another antibiotic, in the treatment of adults with chronic bronchitis experiencing rapid onset of worsening of symptoms caused by bacteria.
NCT00257140 ↗ A Study of the Safety and Effectiveness of Levofloxacin Compared With Cefaclor in the Treatment of Adults With Chronic Bronchitis Experiencing Rapid Onset of Worsening of Symptoms Caused by Bacteria Completed Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Phase 2/Phase 3 1931-06-01 The purpose of this study is to evaluate the safety and effectiveness of levofloxacin, an antibiotic, compared with cefaclor, another antibiotic, in the treatment of adults with chronic bronchitis experiencing rapid onset of worsening of symptoms caused by bacteria.
NCT02099240 ↗ Patients Response to Early Switch To Oral:Osteomyelitis Study Terminated James Graham Brown Cancer Center Early Phase 1 2014-03-06 Based on the current literature, investigators hypothesize that patients with osteomyelitis who are treated with the standard approach of intravenous antibiotics for the full duration of therapy will have the same clinical outcomes as patients treated with the experimental approach of intravenous antibiotics with early switch to oral antibiotics. The primary objective of this study is to compare patients with osteomyelitis treated with the standard approach of intravenous antibiotics for the full duration of therapy versus patients treated with intravenous antibiotics with an early switch to oral antibiotics in relation to clinical outcomes at 12 months after discontinuation of antibiotic therapy. Secondary objectives of the study include the evaluation of adverse events related to the use of antibiotics as well as the cost of care evaluated from the hospital perspective.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for CEFACLOR

Condition Name

Condition Name for CEFACLOR
Intervention Trials
Bronchitis 1
Bronchitis, Chronic 1
Endocarditis Infective 1
Osteomyelitis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for CEFACLOR
Intervention Trials
Urinary Tract Infections 1
Endocarditis, Bacterial 1
Infections 1
Endocarditis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for CEFACLOR

Trials by Country

Trials by Country for CEFACLOR
Location Trials
United States 2
Spain 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for CEFACLOR
Location Trials
Kentucky 1
Washington 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for CEFACLOR

Clinical Trial Phase

Clinical Trial Phase for CEFACLOR
Clinical Trial Phase Trials
Phase 4 1
Phase 2/Phase 3 1
N/A 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for CEFACLOR
Clinical Trial Phase Trials
Completed 2
Not yet recruiting 1
Terminated 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for CEFACLOR

Sponsor Name

Sponsor Name for CEFACLOR
Sponsor Trials
National Center for Complementary and Integrative Health (NCCIH) 1
PriCara, Unit of Ortho-McNeil, Inc. 1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for CEFACLOR
Sponsor Trials
Other 4
Industry 2
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.